(19)
(11) EP 2 502 644 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
04.03.2015 Bulletin 2015/10

(45) Mention of the grant of the patent:
31.12.2014 Bulletin 2015/01

(21) Application number: 12003933.4

(22) Date of filing: 18.05.2011
(51) International Patent Classification (IPC): 
A61M 15/00(2006.01)

(54)

Dose counters for inhalers, inhalers and shafts thereof

Dosiszählwerke für Inhalatoren, Inhalatoren und deren Schäfte

Compteurs de doses pour inhalateurs, inhalateurs et gaines associées

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 18.05.2010 US 345763 P
29.11.2010 US 417659 P

(43) Date of publication of application:
26.09.2012 Bulletin 2012/39

(62) Application number of the earlier application in accordance with Art. 76 EPC:
11004101.9 / 2436414

(73) Proprietors:
  • Ivax Pharmaceuticals Ireland
    Waterford (IE)
  • Norton Waterford
    Waterford (IE)
  • TEVA Pharmaceuticals Ireland
    Waterford (IE)

(72) Inventors:
  • Fenlon, Derek
    Enniscorthy, Co. Wexford (IE)
  • Clancy, Paul
    Waterford City (IE)
  • Uschold, Robert Charles
    Leominister, MA 01453 (US)
  • Walsh, Declan
    Gowran, Co. Kilkenny (IE)
  • Kaar, Simon
    Co. Cork (IE)
  • Hazenberg, Jan Geert
    Kilkenny Co. Kilkenny (IE)
  • Buck, Dan Knockane
    Co. Waterford (IE)
  • Karg, Jeffrey A.
    Hopkinton, MA 01748 (US)

(74) Representative: Cottam, David William 
Teva UK Ltd. Global Patent Group Field House Station Approach
Harlow, Essex CM20 2FB
Harlow, Essex CM20 2FB (GB)


(56) References cited: : 
WO-A1-2006/062449
US-A1- 2002 078 949
 GB-A- 2 320 489
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).